Special Drug Use-results Surveillance of Scemblix Tablets

Clinical trial NCT05421091 · COMPLETED

Trial details

NCT number: NCT05421091
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia

Start date: 2022-07-04
Primary completion: 2024-02-29
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.